by The Southern blotting technique is primarily used in molecular biology for detecting specific DNA and RNA sequences in samples separated through gel electrophoresis. It enables identification of particular DNA/RNA samples based on size and sequence complementarity, thus offering researchers and scientists enhanced capabilities in molecular profiling and genomic analysis. The global Southern Blotting Market is estimated to be valued at US$ 2.8 billion in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing health awareness among consumers has led to the growth of the nutraceuticals market in recent years. As nutraceuticals undergo extensive research and clinical trials to ascertain their health benefits, southern blotting serves as an important technique in validating genetic sequences in gene expression studies related to nutraceuticals. It is thus being widely adopted by nutraceutical manufacturers and research institutes to identify biomarkers that substantiate the physiological effects of various nutraceutical ingredients. This widespread application of southern blotting in the expanding nutraceuticals industry will significantly contribute to the market growth over the forecast period.
SWOT Analysis
Strength: The Southern Blotting technique allows the detection and analysis of specific DNA and RNA sequences. It is highly sensitive and specific.
Weaknesses: The Southern Blotting process requires large amounts of radioactive materials and is time-consuming. It also requires specialized equipment and technical expertise.
Opportunities:advancements in non-radioactive labeling techniques are creating new opportunities. Rising R&D spending in biotechnology and life science industries is driving the demand.
Threats:Availability of alternative techniques like PCR and DNA microarrays that are faster and easier to use poses threats to the market. Stringent regulations associated with the use of radioactive materials also limit growth opportunities.
Key Takeaways
The Global Southern Blotting Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market size for 2024 is projected to reach US$ 2.8 Bn, indicating a CAGR of 6.8% during the period.
Regional analysis: North America dominates the global market currently owing to extensive research activities and advanced research infrastructure in the region. However, Asia Pacific is expected to witness the fastest growth over the coming years. This can be attributed to increasing R&D investments by key players to tap into growth opportunities in emerging economies like China and India.
Key players: Key players operating in the Southern Blotting market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. These players are focusing on new product launches and expansion strategies to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
